
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Turku Centre for Biotechnology, Turku University, 2 Åbo Akademi University, 3 Turku Graduate School of Biomedical Sciences, Departments of 4 Oncology and Radiotherapy, 5 Otorhinolaryngology-Head and Neck Surgery, 6 Medical Biochemistry, and 7 Pathology, Turku University and Turku University Hospital, Turku, Finland
Requests for reprints: Panu M. Jaakkola, Turku Centre for Biotechnology, Tykistökatu 6B, FIN-20520, Turku, Finland. Phone: 358-2333-8030; Fax: 358-2333-8000; E-mail: panjaa{at}utu.fi.
Purpose: Hypoxia in tumors is associated with poor prognosis and resistance to treatment. The outcome of hypoxia is largely regulated by the hypoxia-inducible factors (HIF-1
and HIF-2
). HIFs in turn are negatively regulated by a family of prolyl hydroxylases (PHD1-3). The PHD2 isoform is the main down-regulator of HIFs in normoxia and mild hypoxia. This study was designed to analyze the correlation of the expression and subcellular localization of PHD2 with the pathologic features of human carcinomas and HIF-1
expression.
Experimental Design: The expression of PHD2 was studied from paraffin-embedded normal tissue (n = 21) and head and neck squamous cell carcinoma (HNSCC; n = 44) by immunohistochemistry. Further studies included PHD2 mRNA detection and HIF-1
immunohistochemistry from HNSCC specimens as well as PHD2 immunocytochemistry from HNSCC-derived cell lines.
Results: In noncancerous tissue, PHD2 is robustly expressed by endothelial cells. In epithelium, the basal proliferating layer also shows strong expression, whereas the more differentiated epithelium shows little or no PHD2 expression. In HNSCC, PHD2 shows strongly elevated expression both at the mRNA and protein level. Moreover, PHD2 expression increases in less differentiated phenotypes and partially relocalizes from the cytoplasm into the nucleus. Endogenously high nuclear PHD2 is seen in a subset of HNSCC-derived cell lines. Finally, although most of the tumor regions with high PHD2 expression show down-regulated HIF-1
, regions with simultaneous HIF-1
and PHD2 expression could be detected.
Conclusions: Our results show that increased levels and nuclear translocation of the cellular oxygen sensor, PHD2, are associated with less differentiated and strongly proliferating tumors. Furthermore, they imply that even the elevated PHD2 levels are not sufficient to down-regulate HIF-1
in some tumors.
This article has been cited by other articles:
![]() |
U. Berchner-Pfannschmidt, S. Tug, B. Trinidad, F. Oehme, H. Yamac, C. Wotzlaw, I. Flamme, and J. Fandrey Nuclear Oxygen Sensing: Induction of Endogenous Prolyl-hydroxylase 2 Activity by Hypoxia and Nitric Oxide J. Biol. Chem., November 14, 2008; 283(46): 31745 - 31753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Couvelard, L. Deschamps, V. Rebours, A. Sauvanet, K. Gatter, F. Pezzella, P. Ruszniewski, and P. Bedossa Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors Clin. Cancer Res., October 15, 2008; 14(20): 6634 - 6639. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Berchner-Pfannschmidt, S. Frede, C. Wotzlaw, and J. Fandrey Imaging of the hypoxia-inducible factor pathway: insights into oxygen sensing Eur. Respir. J., July 1, 2008; 32(1): 210 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rantanen, J. Pursiheimo, H. Hogel, V. Himanen, E. Metzen, and P. M. Jaakkola Prolyl Hydroxylase PHD3 Activates Oxygen-dependent Protein Aggregation Mol. Biol. Cell, May 1, 2008; 19(5): 2231 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kassie, L. B. Anderson, L. Higgins, Y. Pan, I. Matise, M. Negia, P. Upadhyaya, M. Wang, and S. S. Hecht Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice Carcinogenesis, March 1, 2008; 29(3): 610 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fandrey, T. A. Gorr, and M. Gassmann Regulating cellular oxygen sensing by hydroxylation Cardiovasc Res, September 1, 2006; 71(4): 642 - 651. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |